> top > docs > PMC:7536950 > annotations

PMC:7536950 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 838-842 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T2 902-925 Body_part denotes hematopoietic stem cell http://purl.org/sig/ont/fma/fma86475
T3 921-925 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T4 1053-1065 Body_part denotes T‐lymphocyte http://purl.org/sig/ont/fma/fma62870
T5 1864-1874 Body_part denotes neutrophil http://purl.org/sig/ont/fma/fma62860
T6 2222-2236 Body_part denotes cranial nerves http://purl.org/sig/ont/fma/fma63820
T7 2274-2278 Body_part denotes limb http://purl.org/sig/ont/fma/fma7182
T8 2483-2496 Body_part denotes facial nerves http://purl.org/sig/ont/fma/fma50868
T9 2512-2534 Body_part denotes left hypoglossal nerve http://purl.org/sig/ont/fma/fma50903
T10 2644-2663 Body_part denotes Cerebrospinal fluid http://purl.org/sig/ont/fma/fma20935
T11 2665-2668 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T12 2737-2744 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T13 2791-2798 Body_part denotes glucose http://purl.org/sig/ont/fma/fma82743
T14 2809-2826 Body_part denotes white blood cells http://purl.org/sig/ont/fma/fma62852
T15 2821-2826 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T16 2858-2861 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T17 3097-3100 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T18 3192-3199 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T19 3287-3292 Body_part denotes brain http://purl.org/sig/ont/fma/fma50801
T20 3349-3363 Body_part denotes Cranial nerves http://purl.org/sig/ont/fma/fma63820
T21 3436-3453 Body_part denotes hypoglossal nerve http://purl.org/sig/ont/fma/fma50871
T22 3507-3520 Body_part denotes facial nerves http://purl.org/sig/ont/fma/fma50868
T23 3547-3561 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871
T24 3799-3804 Body_part denotes Chest http://purl.org/sig/ont/fma/fma9576
T25 3969-3974 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T26 3983-3986 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T27 4321-4335 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871
T28 4997-5013 Body_part denotes peripheral nerve http://purl.org/sig/ont/fma/fma65239
T29 5400-5426 Body_part denotes peripheral nervous systems http://purl.org/sig/ont/fma/fma9903
T30 5642-5645 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T31 5922-5926 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T32 6127-6143 Body_part denotes peripheral nerve http://purl.org/sig/ont/fma/fma65239
T33 6464-6477 Body_part denotes Cranial nerve http://purl.org/sig/ont/fma/fma5865

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 2222-2236 Body_part denotes cranial nerves http://purl.obolibrary.org/obo/UBERON_0001785
T2 2274-2278 Body_part denotes limb http://purl.obolibrary.org/obo/UBERON_0002101
T3 2483-2496 Body_part denotes facial nerves http://purl.obolibrary.org/obo/UBERON_0001647
T4 2517-2534 Body_part denotes hypoglossal nerve http://purl.obolibrary.org/obo/UBERON_0001650
T5 2529-2534 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021
T6 2644-2663 Body_part denotes Cerebrospinal fluid http://purl.obolibrary.org/obo/UBERON_0001359
T7 2815-2820 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T8 3287-3292 Body_part denotes brain http://purl.obolibrary.org/obo/UBERON_0000955
T9 3349-3363 Body_part denotes Cranial nerves http://purl.obolibrary.org/obo/UBERON_0001785
T10 3436-3453 Body_part denotes hypoglossal nerve http://purl.obolibrary.org/obo/UBERON_0001650
T11 3448-3453 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021
T12 3507-3520 Body_part denotes facial nerves http://purl.obolibrary.org/obo/UBERON_0001647
T13 3799-3804 Body_part denotes Chest http://purl.obolibrary.org/obo/UBERON_0001443
T14 3969-3974 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T15 5008-5013 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021
T16 5400-5426 Body_part denotes peripheral nervous systems http://purl.obolibrary.org/obo/UBERON_0000010
T17 6138-6143 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021
T18 6464-6477 Body_part denotes Cranial nerve http://purl.obolibrary.org/obo/UBERON_0001785
T19 6472-6477 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 8-22 Disease denotes polyneuropathy http://purl.obolibrary.org/obo/MONDO_0001824
T2 62-70 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 119-143 Disease denotes Coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T4 145-153 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 276-291 Disease denotes viral pneumonia http://purl.obolibrary.org/obo/MONDO_0006012
T6 282-291 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T7 495-503 Disease denotes diarrhea http://purl.obolibrary.org/obo/MONDO_0001673
T8 770-778 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T9 831-849 Disease denotes sickle cell anemia http://purl.obolibrary.org/obo/MONDO_0011382
T10 843-849 Disease denotes anemia http://purl.obolibrary.org/obo/MONDO_0002280
T11 1077-1102 Disease denotes Graft‐versus‐host disease http://purl.obolibrary.org/obo/MONDO_0013730
T12 1235-1245 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T13 1425-1434 Disease denotes mucositis http://purl.obolibrary.org/obo/MONDO_0000888|http://purl.obolibrary.org/obo/MONDO_0020579
T15 1462-1476 Disease denotes herpes simplex http://purl.obolibrary.org/obo/MONDO_0004609
T16 1629-1640 Disease denotes neutropenia http://purl.obolibrary.org/obo/MONDO_0001475
T17 1901-1910 Disease denotes mucositis http://purl.obolibrary.org/obo/MONDO_0000888|http://purl.obolibrary.org/obo/MONDO_0020579
T19 2055-2067 Disease denotes facial palsy http://purl.obolibrary.org/obo/MONDO_0001835|http://purl.obolibrary.org/obo/MONDO_0005665
T21 2062-2067 Disease denotes palsy http://purl.obolibrary.org/obo/MONDO_0006496
T22 2601-2609 Disease denotes ischemia http://purl.obolibrary.org/obo/MONDO_0005053
T23 2614-2618 Disease denotes PRES http://purl.obolibrary.org/obo/MONDO_0044033
T24 2958-2967 Disease denotes varicella http://purl.obolibrary.org/obo/MONDO_0005700
T25 3014-3018 Disease denotes HHV8 http://purl.obolibrary.org/obo/MONDO_0005055
T26 3331-3334 Disease denotes TSE http://purl.obolibrary.org/obo/MONDO_0018926
T27 3876-3884 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T28 3886-3890 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T29 4056-4091 Disease denotes Acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T30 4062-4091 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T31 4521-4535 Disease denotes polyneuropathy http://purl.obolibrary.org/obo/MONDO_0001824
T32 4561-4565 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T33 4616-4623 Disease denotes COVID19 http://purl.obolibrary.org/obo/MONDO_0100096
T34 4803-4809 Disease denotes ataxia http://purl.obolibrary.org/obo/MONDO_0000437
T35 4871-4888 Disease denotes vision impairment http://purl.obolibrary.org/obo/MONDO_0001941
T36 5035-5059 Disease denotes Guillain‐Barré syndromes http://purl.obolibrary.org/obo/MONDO_0016218
T37 5061-5064 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T38 5101-5109 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T39 5258-5261 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T40 5280-5288 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T41 5364-5372 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T42 5462-5476 Disease denotes polyneuropathy http://purl.obolibrary.org/obo/MONDO_0001824
T43 5683-5686 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T44 5835-5849 Disease denotes polyneuropathy http://purl.obolibrary.org/obo/MONDO_0001824
T45 5915-5933 Disease denotes sickle cell anemia http://purl.obolibrary.org/obo/MONDO_0011382
T46 5927-5933 Disease denotes anemia http://purl.obolibrary.org/obo/MONDO_0002280
T47 5944-5954 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T48 6000-6004 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T49 6039-6053 Disease denotes polyneuropathy http://purl.obolibrary.org/obo/MONDO_0001824
T50 6179-6187 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T51 6243-6264 Disease denotes peripheral neuropathy http://purl.obolibrary.org/obo/MONDO_0003620|http://purl.obolibrary.org/obo/MONDO_0005244
T53 6281-6284 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T54 6331-6335 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T55 6342-6351 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T56 6771-6780 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T57 6786-6790 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 53-54 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T2 74-75 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T3 155-158 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T4 166-167 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5 720-721 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 782-785 http://purl.obolibrary.org/obo/CLO_0001602 denotes a 6
T7 782-785 http://purl.obolibrary.org/obo/CLO_0001603 denotes a 6
T8 782-785 http://purl.obolibrary.org/obo/CLO_0050248 denotes a 6
T9 782-785 http://purl.obolibrary.org/obo/CLO_0052463 denotes a 6
T10 838-842 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T11 916-925 http://purl.obolibrary.org/obo/CL_0000034 denotes stem cell
T12 954-955 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T13 1154-1155 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T14 1334-1339 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T15 1477-1482 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T16 2230-2236 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerves
T17 2274-2278 http://www.ebi.ac.uk/efo/EFO_0000876 denotes limb
T18 2361-2362 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T19 2410-2412 http://purl.obolibrary.org/obo/CLO_0050160 denotes T2
T20 2490-2496 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerves
T21 2529-2534 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve
T22 2693-2695 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T23 2815-2826 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood cells
T24 2987-2992 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T25 3088-3089 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T26 3123-3125 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T27 3287-3292 http://purl.obolibrary.org/obo/UBERON_0000955 denotes brain
T28 3287-3292 http://www.ebi.ac.uk/efo/EFO_0000302 denotes brain
T29 3357-3363 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerves
T30 3448-3453 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve
T31 3514-3520 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerves
T32 3591-3593 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T33 3799-3804 http://www.ebi.ac.uk/efo/EFO_0000965 denotes Chest
T34 3969-3974 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T35 3969-3974 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T36 4290-4291 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T37 4351-4353 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T38 4511-4512 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T39 4539-4540 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T40 4656-4658 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T41 4669-4670 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T42 4746-4747 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T43 4825-4826 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T44 4997-5013 http://purl.obolibrary.org/obo/UBERON_0001021 denotes peripheral nerve
T45 5217-5218 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T46 5315-5316 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T47 5400-5426 http://purl.obolibrary.org/obo/UBERON_0000010 denotes peripheral nervous systems
T48 5400-5426 http://www.ebi.ac.uk/efo/EFO_0000891 denotes peripheral nervous systems
T49 5575-5581 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerves
T50 5662-5663 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T51 5703-5704 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T52 5869-5870 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T53 5922-5926 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T54 6127-6143 http://purl.obolibrary.org/obo/UBERON_0001021 denotes peripheral nerve
T55 6410-6415 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T56 6445-6446 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T57 6472-6477 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 972-977 Chemical denotes donor http://purl.obolibrary.org/obo/CHEBI_17891
T2 1016-1024 Chemical denotes busulfan http://purl.obolibrary.org/obo/CHEBI_28901
T3 1026-1042 Chemical denotes cyclophosphamide http://purl.obolibrary.org/obo/CHEBI_4026|http://purl.obolibrary.org/obo/CHEBI_4027
T5 1140-1152 Chemical denotes methotrexate http://purl.obolibrary.org/obo/CHEBI_44185|http://purl.obolibrary.org/obo/CHEBI_50681
T7 1398-1407 Chemical denotes rituximab http://purl.obolibrary.org/obo/CHEBI_64357
T8 1588-1597 Chemical denotes acyclovir http://purl.obolibrary.org/obo/CHEBI_2453
T9 1735-1746 Chemical denotes antibiotics http://purl.obolibrary.org/obo/CHEBI_33281
T10 1748-1760 Chemical denotes piperacillin http://purl.obolibrary.org/obo/CHEBI_8232
T11 1761-1771 Chemical denotes tazobactam http://purl.obolibrary.org/obo/CHEBI_9421
T12 1790-1801 Chemical denotes vancomycine http://purl.obolibrary.org/obo/CHEBI_28001
T13 1820-1833 Chemical denotes ciprofloxacin http://purl.obolibrary.org/obo/CHEBI_100241
T14 1931-1942 Chemical denotes antibiotics http://purl.obolibrary.org/obo/CHEBI_33281
T15 1961-1970 Chemical denotes acyclovir http://purl.obolibrary.org/obo/CHEBI_2453
T16 2410-2412 Chemical denotes T2 http://purl.obolibrary.org/obo/CHEBI_29298|http://purl.obolibrary.org/obo/CHEBI_75710
T18 2544-2554 Chemical denotes gadolinium http://purl.obolibrary.org/obo/CHEBI_33375
T19 2737-2744 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T20 2791-2798 Chemical denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167
T22 3073-3086 Chemical denotes nucleic acids http://purl.obolibrary.org/obo/CHEBI_33696
T23 3081-3086 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T24 3192-3199 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T25 3381-3391 Chemical denotes gadolinium http://purl.obolibrary.org/obo/CHEBI_33375
T26 4257-4268 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2 8-22 Disease denotes polyneuropathy MESH:D011115
3 62-70 Disease denotes COVID‐19 MESH:C000657245
19 299-307 Species denotes children Tax:9606
20 589-597 Species denotes children Tax:9606
21 676-687 Species denotes coronavirus Tax:11118
22 119-143 Disease denotes Coronavirus disease 2019 MESH:C000657245
23 145-153 Disease denotes COVID‐19 MESH:C000657245
24 225-245 Disease denotes respiratory distress MESH:D012128
25 276-291 Disease denotes viral pneumonia
26 427-432 Disease denotes fever MESH:D005334
27 434-443 Disease denotes tachypnea MESH:D059246
28 456-461 Disease denotes cough MESH:D003371
29 478-484 Disease denotes nausea MESH:D009325
30 485-493 Disease denotes vomiting MESH:D014839
31 495-503 Disease denotes diarrhea MESH:D003967
32 508-516 Disease denotes asthenia MESH:D001247
33 529-550 Disease denotes neurological symptoms MESH:D009422
44 795-802 Species denotes patient Tax:9606
45 808-815 Species denotes patient Tax:9606
46 1016-1024 Chemical denotes busulfan MESH:D002066
47 1026-1042 Chemical denotes cyclophosphamide MESH:D003520
48 1124-1135 Chemical denotes cyclosporin MESH:D016572
49 1140-1152 Chemical denotes methotrexate MESH:D008727
50 770-778 Disease denotes COVID‐19 MESH:C000657245
51 843-849 Disease denotes anemia MESH:D000740
52 865-886 Disease denotes cerebral vasculopathy MESH:C566007
53 1077-1102 Disease denotes Graft‐versus‐host disease MESH:D006086
57 1321-1339 Species denotes Epstein‐Barr virus Tax:10376
58 1341-1344 Species denotes EBV Tax:10376
59 1398-1407 Chemical denotes rituximab MESH:D000069283
64 1462-1484 Species denotes herpes simplex virus‐1 Tax:10298
65 1486-1491 Species denotes HSV‐1 Tax:10298
66 1588-1597 Chemical denotes acyclovir MESH:D000212
67 1425-1434 Disease denotes mucositis MESH:D052016
73 1648-1653 Species denotes HSV‐1 Tax:10298
74 1748-1771 Chemical denotes piperacillin‐tazobactam MESH:D000077725
75 1790-1801 Chemical denotes vancomycine MESH:D014640
76 1820-1833 Chemical denotes ciprofloxacin MESH:D002939
77 1616-1640 Disease denotes long febrile neutropenia MESH:D009503
79 1235-1259 Disease denotes infectious complications MESH:D011251
82 1961-1970 Chemical denotes acyclovir MESH:D000212
83 1901-1910 Disease denotes mucositis MESH:D052016
88 2022-2029 Species denotes patient Tax:9606
89 2045-2067 Disease denotes bilateral facial palsy MESH:D005158
90 2069-2097 Disease denotes left trigeminal hypoesthesia MESH:D006987
91 2274-2313 Disease denotes limb sensory‐motor deficit or areflexia MESH:D000071699
106 2829-2831 Gene denotes μL Gene:4591
107 3181-3199 Gene denotes C‐reactive protein Gene:1401
108 3201-3204 Gene denotes CRP Gene:1401
109 2853-2855 Gene denotes μL Gene:4591
110 2987-2992 Species denotes human Tax:9606
111 2993-3004 Species denotes Herpesvirus Tax:39059
112 3006-3012 Species denotes HHV) 6 Tax:10368
113 3014-3018 Species denotes HHV8 Tax:37296
114 3020-3030 Species denotes adenovirus Tax:10508
115 2982-2985 Species denotes EBV Tax:10376
116 2544-2554 Chemical denotes gadolinium MESH:D005682
117 2791-2798 Chemical denotes glucose MESH:D005947
118 2589-2599 Disease denotes hemorrhage MESH:D006470
119 2601-2609 Disease denotes ischemia MESH:D007511
121 3381-3391 Chemical denotes gadolinium MESH:D005682
133 3778-3781 Gene denotes CRP Gene:1401
134 3886-3896 Species denotes SARS‐CoV‐2 Tax:2697049
135 4024-4034 Species denotes adenovirus Tax:10508
136 4006-4009 Species denotes EBV Tax:10376
137 3622-3627 Disease denotes Fever MESH:D005334
138 3632-3652 Disease denotes respiratory symptoms MESH:D012818
139 3711-3732 Disease denotes neurological symptoms MESH:D009422
140 3750-3755 Disease denotes cough MESH:D003371
141 3760-3765 Disease denotes fever MESH:D005334
142 3876-3884 Disease denotes COVID‐19 MESH:C000657245
143 4056-4091 Disease denotes Acute respiratory distress syndrome MESH:D012128
148 4149-4156 Species denotes patient Tax:9606
149 4235-4245 Chemical denotes remdesevir
150 4257-4268 Chemical denotes tocilizumab MESH:C502936
151 4355-4370 Disease denotes Facial diplegia MESH:C531747
180 4541-4546 Species denotes child Tax:9606
181 4561-4571 Species denotes SARS‐CoV‐2 Tax:2697049
182 4697-4705 Species denotes patients Tax:9606
183 4958-4966 Species denotes patients Tax:9606
184 5305-5313 Species denotes children Tax:9606
185 5731-5738 Species denotes patient Tax:9606
186 6000-6010 Species denotes SARS‐CoV‐2 Tax:2697049
187 5956-5959 Species denotes EBV Tax:10376
188 4513-4535 Disease denotes cranial polyneuropathy MESH:D011115
189 4547-4555 Disease denotes infected MESH:D007239
190 4616-4623 Disease denotes COVID19 MESH:C000657245
191 4782-4791 Disease denotes dizziness MESH:D004244
192 4793-4801 Disease denotes headache MESH:D006261
193 4803-4809 Disease denotes ataxia MESH:D001259
194 4815-4822 Disease denotes seizure MESH:D012640
195 4871-4888 Disease denotes vision impairment MESH:D014786
196 4894-4910 Disease denotes neuropathic pain MESH:D009437
197 4920-4945 Disease denotes skeletal muscular failure MESH:D006333
198 5101-5109 Disease denotes COVID‐19 MESH:C000657245
199 5174-5200 Disease denotes facial paresia or diplegia MESH:C531747
200 5280-5288 Disease denotes COVID‐19 MESH:C000657245
201 5364-5372 Disease denotes COVID‐19 MESH:C000657245
202 5454-5476 Disease denotes cranial polyneuropathy MESH:D011115
203 5760-5781 Disease denotes cerebral vasculopathy MESH:C566007
204 5827-5849 Disease denotes cranial polyneuropathy MESH:D011115
205 5927-5933 Disease denotes anemia MESH:D000740
206 5935-5954 Disease denotes Viral co‐infections MESH:D001102
207 6039-6053 Disease denotes polyneuropathy MESH:D011115
213 6222-6230 Species denotes children Tax:9606
214 6573-6581 Species denotes patients Tax:9606
215 6179-6187 Disease denotes COVID‐19 MESH:C000657245
216 6243-6264 Disease denotes peripheral neuropathy MESH:D010523
217 6331-6351 Disease denotes SARS‐CoV‐2 infection MESH:C000657245

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 8-22 Phenotype denotes polyneuropathy http://purl.obolibrary.org/obo/HP_0001271
T2 225-245 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T3 282-291 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T4 427-432 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T5 434-443 Phenotype denotes tachypnea http://purl.obolibrary.org/obo/HP_0002789
T6 445-461 Phenotype denotes productive cough http://purl.obolibrary.org/obo/HP_0031245
T7 478-493 Phenotype denotes nausea/vomiting http://purl.obolibrary.org/obo/HP_0002017
T8 495-503 Phenotype denotes diarrhea http://purl.obolibrary.org/obo/HP_0002014
T9 508-516 Phenotype denotes asthenia http://purl.obolibrary.org/obo/HP_0025406
T10 843-849 Phenotype denotes anemia http://purl.obolibrary.org/obo/HP_0001903
T11 1629-1640 Phenotype denotes neutropenia http://purl.obolibrary.org/obo/HP_0001875
T12 2045-2067 Phenotype denotes bilateral facial palsy http://purl.obolibrary.org/obo/HP_0430025
T13 2085-2097 Phenotype denotes hypoesthesia http://purl.obolibrary.org/obo/HP_0003474
T14 2304-2313 Phenotype denotes areflexia http://purl.obolibrary.org/obo/HP_0001284
T15 3622-3627 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T16 3739-3755 Phenotype denotes productive cough http://purl.obolibrary.org/obo/HP_0031245
T17 3760-3765 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T18 4062-4082 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T19 4355-4370 Phenotype denotes Facial diplegia http://purl.obolibrary.org/obo/HP_0001349
T20 4521-4535 Phenotype denotes polyneuropathy http://purl.obolibrary.org/obo/HP_0001271
T21 4782-4791 Phenotype denotes dizziness http://purl.obolibrary.org/obo/HP_0002321
T22 4793-4801 Phenotype denotes headache http://purl.obolibrary.org/obo/HP_0002315
T23 4803-4809 Phenotype denotes ataxia http://purl.obolibrary.org/obo/HP_0001251
T24 4815-4822 Phenotype denotes seizure http://purl.obolibrary.org/obo/HP_0001250
T25 4906-4910 Phenotype denotes pain http://purl.obolibrary.org/obo/HP_0012531
T26 4997-5020 Phenotype denotes peripheral nerve damage http://purl.obolibrary.org/obo/HP_0009830
T27 5462-5476 Phenotype denotes polyneuropathy http://purl.obolibrary.org/obo/HP_0001271
T28 5835-5849 Phenotype denotes polyneuropathy http://purl.obolibrary.org/obo/HP_0001271
T29 5927-5933 Phenotype denotes anemia http://purl.obolibrary.org/obo/HP_0001903
T30 6039-6053 Phenotype denotes polyneuropathy http://purl.obolibrary.org/obo/HP_0001271
T31 6243-6264 Phenotype denotes peripheral neuropathy http://purl.obolibrary.org/obo/HP_0009830
T32 6464-6489 Phenotype denotes Cranial nerve involvement http://purl.obolibrary.org/obo/HP_0001291

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 632-639 http://purl.obolibrary.org/obo/GO_0009606 denotes tropism
T2 1523-1536 http://purl.obolibrary.org/obo/GO_0051179 denotes localizations
T3 3905-3918 http://purl.obolibrary.org/obo/GO_0003968 denotes transcriptase
T4 3905-3918 http://purl.obolibrary.org/obo/GO_0003899 denotes transcriptase
T5 4854-4859 http://purl.obolibrary.org/obo/GO_0050909 denotes taste
T6 4871-4877 http://purl.obolibrary.org/obo/GO_0007601 denotes vision
T7 6018-6030 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T8 6397-6415 http://purl.obolibrary.org/obo/GO_0009597 denotes detection of virus

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-81 Sentence denotes Cranial polyneuropathy as the first manifestation of a severe COVID‐19 in a child
T2 82-102 Sentence denotes LETTER TO THE EDITOR
T3 104-118 Sentence denotes To the Editor:
T4 119-191 Sentence denotes Coronavirus disease 2019 (COVID‐19) has led to a pandemic in early 2020.
T5 192-292 Sentence denotes The typical clinical syndrome is respiratory distress, leading ultimately to severe viral pneumonia.
T6 293-363 Sentence denotes 1 In children, symptoms are reported to be milder compared to adults.
T7 364-517 Sentence denotes 2 , 3 In severely ill pediatric cases, the main symptoms are fever, tachypnea, productive cough, expectoration, nausea/vomiting, diarrhea and asthenia.
T8 518-695 Sentence denotes 4 Various neurological symptoms have also been reported in adults and children, consistent with the neurological tropism reported for certain members of the coronavirus family.
T9 696-702 Sentence denotes 5 , 6
T10 703-803 Sentence denotes We herein report a novel neurological presentation associated with COVID‐19 in a 6‐year‐old patient.
T11 804-887 Sentence denotes The patient presented with sickle cell anemia complicated by cerebral vasculopathy.
T12 888-1076 Sentence denotes She underwent hematopoietic stem cell transplantation (HSCT) from a matched‐related donor following myeloablative conditioning (busulfan, cyclophosphamide, and anti‐T‐lymphocyte globulin).
T13 1077-1153 Sentence denotes Graft‐versus‐host disease prophylaxis included cyclosporin and methotrexate.
T14 1154-1226 Sentence denotes A historical timeline is presented in the Supporting Information figure.
T15 1227-1307 Sentence denotes Various infectious complications occurred around the date of transplant (day 0):
T16 1308-1417 Sentence denotes Asymptomatic Epstein‐Barr virus (EBV) replication starting from day −14, treated with one rituximab infusion.
T17 1418-1598 Sentence denotes Severe mucositis, aggravated by concomitant herpes simplex virus‐1 (HSV‐1) reactivation (oral and pelvic localizations), early after conditioning, treated with high dose acyclovir.
T18 1599-1852 Sentence denotes Forty‐eight‐hour long febrile neutropenia during HSV‐1 reactivation, without other microbial documentation, treated with broad‐spectrum antibiotics (piperacillin‐tazobactam from day 0 to 20, vancomycine from day 2 to 15, ciprofloxacin from day 2 to 10).
T19 1853-2006 Sentence denotes At day 20, neutrophil engraftment was acheived, mucositis/HSV lesions healed, antibiotics were stopped, and acyclovir was switched to prophylactic doses.
T20 2007-2166 Sentence denotes At day 21, the patient presented with bilateral facial palsy, left trigeminal hypoesthesia, and voice alteration, followed 24 h later by swallowing impairment.
T21 2167-2314 Sentence denotes The full clinical picture was limited to impairment of cranial nerves V, VII, and IX, with no evidence for limb sensory‐motor deficit or areflexia.
T22 2315-2567 Sentence denotes Cerebral magnetic resonance imagery performed a few hours after onset of symptoms demonstrated T2‐FLAIR hypersignals of the intracranial and meatal segments of the two facial nerves as well as the left hypoglossal nerve, with T1 gadolinium enhancement.
T23 2568-2643 Sentence denotes There was no sign of hemorrhage, ischemia, or PRES syndrome (see Figure 1).
T24 2644-2857 Sentence denotes Cerebrospinal fluid (CSF) examination, performed 18 h after onset of symptoms , found normal protein level 25 mg/dL (reference range 15‐60 mg/dL), glucose 66 mg/dL, white blood cells 1/μL (reference range 0‐5/μL).
T25 2858-3087 Sentence denotes CSF Gram stain and culture were negative, as well as polymerase chain reaction (PCR) targeting HSV, varicella, enterovirus, EBV, human Herpesvirus (HHV) 6, HHV8, adenovirus, mycoplasma, Cryptococcus, and toxoplasma nucleic acids.
T26 3088-3180 Sentence denotes A second CSF examination performed 48 h after onset of symptoms was also found unconclusive.
T27 3181-3260 Sentence denotes C‐reactive protein (CRP) never exceeded 10 mg/L during this neurological phase.
T28 3261-3348 Sentence denotes FIGURE 1 Axial slices of brain magnetic resonance imagery (MRI) (T1w TSE SPIR images).
T29 3349-3621 Sentence denotes Cranial nerves enhancement upon gadolinium injection is shown: blue arrow pointing the hypoglossal nerve (left panel) and the two red arrows pointing the two facial nerves (right panel) Intravenous immunoglobulin (1 g/kg) was infused at days 22 and 23 without improvement.
T30 3622-3777 Sentence denotes Fever and respiratory symptoms appeared secondarily at day 25, 4 days after the onset of neurological symptoms, with productive cough and fever up to 40°C.
T31 3778-3798 Sentence denotes CRP remained normal.
T32 3799-3885 Sentence denotes Chest computerized tomography scan showed images characteristic of pulmonary COVID‐19.
T33 3886-3987 Sentence denotes SARS‐CoV‐2 reverse transcriptase‐PCR assay was positive in nasopharyngeal swab and blood, not in CSF.
T34 3988-4055 Sentence denotes No replication of EBV, HSV, CMV, or adenovirus could be documented.
T35 4056-4144 Sentence denotes Acute respiratory distress syndrome led to transfer to an intensive care unit at day 29.
T36 4145-4354 Sentence denotes The patient required protective mechanical ventilation for 17 days, received treatment by remdesevir (10 days), tocilizumab (two infusions), and a second course of intravenous immunoglobulin at days 51 and 52.
T37 4355-4416 Sentence denotes Facial diplegia was persistent beyond mechanical ventilation.
T38 4417-4472 Sentence denotes Significant clinical improvement started around day 60.
T39 4473-4572 Sentence denotes This case is the first description of a cranial polyneuropathy in a child infected with SARS‐CoV‐2.
T40 4573-4946 Sentence denotes Neurological symptoms during the course of COVID19 have been reported in more than 35% cases in a recent study of 214 adult patients, 7 with three possible presentations: (a) central manifestations including dizziness, headache, ataxia, and seizure, (b) peripheral symptoms, like taste, smell, or vision impairment, and neuropathic pain, and (c) skeletal muscular failure.
T41 4947-5021 Sentence denotes Of the 214 patients, only five presented isolated peripheral nerve damage.
T42 5022-5201 Sentence denotes Six cases of Guillain‐Barré syndromes (GBS) occurring 5‐10 days after onset of COVID‐19 were recently described in adults, four of them presenting with facial paresia or diplegia.
T43 5202-5298 Sentence denotes 8 One case of a 61‐year‐old was reported with complete GBS preceding typical COVID‐19 symptoms.
T44 5299-5477 Sentence denotes 9 In children, a recent study described neurological signs with COVID‐19 affecting both central and peripheral nervous systems, without reported forms of cranial polyneuropathy.
T45 5478-5687 Sentence denotes 10 Our observation is reminiscent of these reports, with some novel features: only craniofacial nerves were impaired, symptoms were presenting manifestations, and CSF never displayed a classic profile of GBS.
T46 5688-5934 Sentence denotes The context of a heavily immunocompromised patient and the pre‐existing cerebral vasculopathy may explain these discrepancies, even though cranial polyneuropathy is not reported as a classic side effect of HSCT conditioning or sickle cell anemia.
T47 5935-6111 Sentence denotes Viral co‐infections (EBV and HSV) may also have interplayed with SARS‐CoV‐2 in the pathogenesis of this polyneuropathy, although no concomitant replication could be documented.
T48 6112-6188 Sentence denotes In conclusion, peripheral nerve involvement is rarely described in COVID‐19.
T49 6189-6352 Sentence denotes The present report confirms that children can display peripheral neuropathy, reminiscent of GBS or Miller‐Fischer syndromes, with concomitant SARS‐CoV‐2 infection.
T50 6353-6463 Sentence denotes Neurological symptoms may precede or follow detection of virus replication, as described in a few adult cases.
T51 6464-6582 Sentence denotes Cranial nerve involvement might predict an aggressive course of the disease, especially in immunocompromised patients.
T52 6584-6604 Sentence denotes CONFLICT OF INTEREST
T53 6605-6669 Sentence denotes The other authors declare that there is no conflict of interest.
T54 6671-6693 Sentence denotes Supporting information
T55 6694-6715 Sentence denotes Supplementary Figure:
T56 6716-6796 Sentence denotes Timeline of the medical events preceding and following infection with SARS‐CoV‐2
T57 6797-6833 Sentence denotes Click here for additional data file.